微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.81% | 52.09% | 43.46% | 28/157 | 1.37% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 4.05% | 76.09% | -41.73% | 21/157 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 6.95% | 30.64% | 27.06% | 39/157 | -4.46% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 5.47% | -14.53% | 43.19% | 57/157 | 1.31% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 3.82% | 18.63% | 66.09% | 48/157 | 0.3% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 2.3% | -25.81% | -56.77% | 45/157 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 5.32% | 506.11% | -16.88% | 56/157 | -9.62% | 百利天恒药业 | 181.27% | 行业排名> |
| 2024-09-30 | 6.4% | 20.53% | 98.76% | 57/157 | 4.28% | 百利天恒药业 | 186.1% | 行业排名> |
| 2024-06-30 | 3.22% | -5.85% | 3.87% | 60/157 | 2.69% | 百利天恒药业 | 186.89% | 行业排名> |
| 2024-03-31 | 3.1% | 9.54% | 336.64% | 29/157 | 2.35% | 百利天恒药业 | 188.56% | 行业排名> |
| 2023-12-31 | -1.31% | -132.11% | -124.67% | 108/157 | -1% | 上海小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 5.31% | 19.59% | 55.26% | 64/157 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.42% | 34.65% | 20.85% | 64/157 | 1.48% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.83% | 54.64% | -30.64% | 38/157 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 4.08% | 26.32% | -8.11% | 80/157 | 0.79% | 上海小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 4.44% | -37.25% | 74.8% | 68/157 | 2.86% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.54% | 11.65% | 38.8% | 75/157 | 2.21% | 上海小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.83% | -1.08% | -43.34% | 63/157 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 3.23% | 275.58% | -54.35% | 87/157 | 0.84% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 7.08% | 32.71% | 211.03% | 60/157 | 4.46% | 上海小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.28% | -6.69% | 22.97% | 92/157 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.85% | 262.28% | 115.12% | 71/157 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 0.86% | 102.13% | -83.87% | 105/157 | 3.8% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 5.33% | -65.98% | 118.7% | 68/157 | 3.13% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 2.44% | 2670.46% | 313.86% | 83/157 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | -1.14% | -323.53% | 97.18% | 96/157 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | -40.46% | -326.79% | -358.12% | 127/157 | 2.57% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 15.68% | 14687.74% | 17712.5% | 12/157 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 0.09% | 109.44% | -82.75% | 106/157 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.51% | 218.75% | 105.38% | 93/157 | 2.45% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | -9.48% | -351.43% | -9043.4% | 122/157 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 0.11% | 39.47% | 111.37% | 96/157 | 7.21% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | -0.93% | -8372.73% | -682.5% | 100/157 | 4.63% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.16% | 58.42% | 107.62% | 91/157 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | -2.1% | 49.4% | -2863.16% | 117/157 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 0.08% | -83.04% | 790.91% | 93/157 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | -0.01% | 98.19% | -110.89% | 98/157 | 5.56% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.1% | 14.77% | 102.43% | 80/157 | 2.1% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | -4.15% | -108.54% | -1026.34% | 107/157 | 6.05% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 0.45% | 611.11% | 173.56% | 76/157 | 5.64% | ST南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | -0.61% | -254.96% | -792.05% | 83/157 | 3.52% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.09% | 22.22% | 104.42% | 75/157 | 2.69% | 贝达药业 | 16.78% | 行业排名> |